Κατεύθυνση Χειρουργική ΟγκολογίαLibrary of the School of Health Sciences
Δημήτριος Θεοδώρου, Καθηγητής, Ιατρική, ΕΚΠΑ
Μανούσος Κωνσταντουλάκης, Καθηγητής, Ιατρική, ΕΚΠΑ
Κωνσταντίνος Γ. Τούτουζας, Αναπληρωτής Καθηγητής, Ιατρική, ΕΚΠΑ
Ανάπτυξη κακοήθειας μετά από μεταμόσχευση νεφρού – Μελέτη κατά τη χρονική περίοδο 1990 – 2017 στην Ά Χειρουργική κλινική και ΜΜΟ του Γενικού Νοσοκομείου Αθηνών «Ο Ευαγγελισμός»
Development of malignancy after kidney transplantation
The process of transplantation is now the only possible solution for patients experiencing conditions that can not be treated with traditional therapies.One of the most common transplant procedures is that of a kidney transplant.Kidney transplantation, of course, is a particularly serious surgical procedure, and there are also cases where minor or greater complications occur after surgery, which may have different effects on patients.After kidney transplantation, the risk of developing neoplasia, mainly in the skin or the hematopoietic system, is greatly increased.This risk varies according to the patient, depending, among other things, on the type and duration of the immunosuppression he has undergone.As is clear from the guidelines issued by the European Society for the Transplantation of Organs (ESOT) and the European Nephrology Society (ERA - EDTA), kidney transplant recipients are important to be screened for cancer because they are considered to belong to a high - risk.According to the results of this study, 3% of the kidney transplant cases examined developed malignancy during the transplantation period.Of this, 17.4% developed lymphoma and 82.6% cancer.The mean time period of malignancy was 4.5 years, the shortest time was 6 months, and the longer was 10 years.
Main subject category:
Kidney Transplantation, Nephropathy, Complicated, Malignity, Cancer
Voulgaris Sotirios Master.pdf
File access is restricted only to the intranet of UoA.